Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients

Inclusion Criteria: * Subjects must have histologically or cytologically confirmed axillary node positive unilateral breast cancer and may be female or male. * Subjects must have received no prior surgical interventions to the axilla except for core needle biopsy or sentinel node biopsy within 30 days of the planned axillary node dissection. * Age \>18 years. Children are excluded from this study since breast cancer is quite rare in children. * ECOG Performance status 0 or 1 * Subjects must have normal organ and marrow function as defined below: * Leukocytes ≥ 3,000/mcL * Absolute neutrophil count ≥ 1,500/mcL * Platelet count ≥ 100,000/mcL * Total bilirubin within normal institutional limits * AST (SGOT) ≤ 2.5 X institutional upper limit of normal * ALT (SGPT) ≤ 2.5 X institutional upper limit of normal * Serum Creatinine within normal institutional limits * Subjects must have at least one suitable lymphatic and one suitable vein amenable to lymphovenous bypass anastomosis. * Subjects must have the ability to understand and the willingness to sign a written informed consent document. * Patients may be treated with adjuvant or neoadjuvant therapies at the discretion of the treating medical oncologist * Patients may be treated with adjuvant radiation therapy at the discretion of the treating radiation oncologist. * Patients may be treated with either mastectomy or breast conserving surgery at the discretion of the treating surgical oncologist. * In order to comp…